PTC Therapeutics PTCT Business Segments — Other Expense Segment Net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept ptct:OtherExpenseSegmentNet.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's business segments — other expense segment net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's business segments — other expense segment net?
- PTC Therapeutics (PTCT) reported business segments — other expense segment net of $43.13M in Q1 2026.
- How has PTC Therapeutics's business segments — other expense segment net changed year-over-year?
- PTC Therapeutics's business segments — other expense segment net increased by 5.7% year-over-year, from $40.81M to $43.13M.
- What is the long-term trend for PTC Therapeutics's business segments — other expense segment net?
- Over 2 years (2023 to 2025), PTC Therapeutics's business segments — other expense segment net has grown at a -38.5% compound annual growth rate (CAGR), from $418.5M to $158.46M.
- What does business segments — other expense segment net mean?
- This metric aggregates miscellaneous costs and non-recurring charges that do not fall into standard operating expense categories for the Life Science segment. It provides visibility into peripheral financial outflows that impact the segment's net contribution. Monitoring this helps identify hidden operational inefficiencies or one-time events that affect the segment's bottom-line performance.